Insulin glargine - Wikipedia, the free encyclopedia
Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with ...
Insulin pen - Wikipedia, the free encyclopedia
Lantus and Apidra by Sanofi-Aventis; Humulin and Humalog by Eli Lilly Use. Insulin pens are used by 90% to 95% of insulin-treated patients in Europe, Asia, and Scandinavia with excellent ...
Lantus - Pet Diabetes
Lantus is the brand name for insulin glargine, an insulin analog made by Aventis[10]. Lantus is a very long-acting insulin (lasting up to 24 hours in humans) that uses pH ...
INDICATIONS AND USAGE
LANTUS (insulin glargine [recombinant DNA origin]) is a long-acting insulin. Because LANTUS is made by recombinant DNA technology (rDNA) and is chemically different from the ...
LANTUS® (insulin glargine [rDNA origin] injection) Diabetes Therapy
LANTUS® is the only 24-hour insulin approved exclusively for use once a day. As part of a diabetes treatment plan, LANTUS® can help patients with type 1 and type 2 diabetes ...
INSULIN GLARGINE - INJECTABLE (Lantus) side effects, medical uses, and ...
Consumer information about the medication INSULIN GLARGINE - INJECTABLE (Lantus), includes side effects, drug interactions, recommended dosages, and storage information. Read more ...
Lantus Insulin: Link to Cancer Shaky
Experts say patients should not worry about shaky data suggesting a possible slight cancer risk in people with type 2 diabetes who take Lantus, a long-acting insulin.
Lantus Insulin - General Information
General information about Lantus insulin ... What is unique about Lantus? It is the only insulin analog used once a day that is proven to lower basal glucose levels for a full 24 ...
